These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6462106)

  • 1. Penetration of cephalosporins and corresponding 1-oxacephalosporins through the outer layer of Gram-negative bacteria and its contribution to antibacterial activity.
    Murakami K; Yoshida T
    Antimicrob Agents Chemother; 1982 Feb; 21(2):254-8. PubMed ID: 6462106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Oxacephalosporins: enhancement of beta-lactam reactivity and antibacterial activity.
    Murakami K; Takasuka M; Motokawa K; Yoshida T
    J Med Chem; 1981 Jan; 24(1):88-93. PubMed ID: 6451699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
    Vuye A
    Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxalactam (6059-S), a novel 1-oxa-beta-lactam with an expanded antibacterial spectrum: laboratory evaluation.
    Yoshida T; Matsuura S; Mayama M; Kameda Y; Kuwahara S
    Antimicrob Agents Chemother; 1980 Mar; 17(3):302-12. PubMed ID: 6448572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of moxalactam into its target proteins in Escherichia coli K-12: comparison of a highly moxalactam resistant mutant with its parent strain.
    Komatsu Y; Murakami K; Nishikawa T
    Antimicrob Agents Chemother; 1981 Nov; 20(5):613-9. PubMed ID: 6459762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antibacterial activity of moxalactam, a new broad-spectrum semisynthetic antibiotic.
    Skalova R; Hajsig D; Muic V; Kapun D
    Infection; 1980; 8 Suppl 3():S 330-3. PubMed ID: 6447672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
    Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
    Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the 7 alpha-methoxy and side-chain carboxyl of moxalactam in beta-lactamase stability and antibacterial activity.
    Murakami K; Yoshida T
    Antimicrob Agents Chemother; 1981 Jan; 19(1):1-7. PubMed ID: 6454378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
    Goto S
    Rev Infect Dis; 1982; 4 Suppl():S501-10. PubMed ID: 6218559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxalactam: the first of a new class of beta-lactam antibiotics.
    Webber JA; Yoshida T
    Rev Infect Dis; 1982; 4 Suppl():S496-500. PubMed ID: 6218558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Moxalactam: a new group of beta-lactams].
    Fourtillan JB
    Sem Hop; 1983 Jun; 59(26):1947-8. PubMed ID: 6310783
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.
    Tai M; Fukuoka Y; Yotsuji A; Kumano K; Takahata M; Mikami H; Yasuda T; Saikawa I; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Nov; 22(5):728-34. PubMed ID: 6983861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural requirements for antibacterial activity and beta-lactamase stability of 7 beta-arylmalonylamino-7 alpha-methoxy-1-oxacephems.
    Yoshida T
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):231-7. PubMed ID: 6109319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of moxalactam to beta-lactamase.
    Richmond MH
    Rev Infect Dis; 1982; 4 Suppl():S522-6. PubMed ID: 6218561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.
    O'Donnell ED; Freimer EH; Gilardi GL; Raeder R
    Antimicrob Agents Chemother; 1982 Apr; 21(4):673-5. PubMed ID: 6211143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy.
    Fitzpatrick BJ; Standiford HC
    Pharmacotherapy; 1982; 2(4):197-212. PubMed ID: 6221237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
    Schaad UB; McCracken GH; Threlkeld N; Thomas ML
    J Pediatr; 1981 Jan; 98(1):129-36. PubMed ID: 6450277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Hanslo D; King A; Shannon K; Warren C; Phillips I
    J Antimicrob Chemother; 1981 Jun; 7(6):607-17. PubMed ID: 6265426
    [No Abstract]   [Full Text] [Related]  

  • 19. Moxalactam (6059-S), a new 1-oxa-beta-lactam: binding affinity for penicillin-binding proteins of Escherichia coli K-12.
    Komatsu Y; Nishikawa T
    Antimicrob Agents Chemother; 1980 Mar; 17(3):316-21. PubMed ID: 6448573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of antibacterial action of cefprozil, a new cephalosporin, on Escherichia coli, Serratia marcescens and Morganella morganii.
    Nishimoto K; Usui T; Miyake Y; Suginaka H
    Hiroshima J Med Sci; 1991 Mar; 40(1):35-40. PubMed ID: 1864765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.